A recent review finds insufficient evidence to recommend vitamin supplements for dry eye disease, highlighting gaps in clinical trials and urging caution. Dr. Priya Deshmukh examines the findings and their implications for patient care.
Dry eye disease affects over 30% of adults globally, with symptoms ranging from irritation to vision impairment. While artificial tears and anti-inflammatory medications remain mainstays of treatment, patient interest in nutritional interventions has surged. A 2026 meta-analysis published in Optometry and Vision Science evaluated 27 clinical trials on vitamin supplementation for dry eye, concluding that evidence remains inconclusive due to inconsistent methodologies and slight sample sizes. This raises critical questions about the role of vitamins like A, C, E, and B12 in ocular health.
In Plain English: The Clinical Takeaway
- There is no strong evidence that vitamin supplements cure or prevent dry eye disease.
- Patients should consult a healthcare provider before starting any supplement regimen.
- Current treatments like prescription eye drops and lifestyle adjustments remain more effective.
The review by Hamidreza Heidari and colleagues at UNSW Sydney underscores the need for rigor in studying nutritional interventions. For instance, vitamin A deficiency is linked to xerophthalmia, a severe form of dry eye, but most modern cases stem from environmental factors or aging, not dietary insufficiency. A 2023 study in JAMA Ophthalmology found that while vitamin A supplementation improved corneal health in malnourished populations, its benefits for otherwise healthy individuals were negligible.
Why the Evidence Falls Short
Many trials on vitamins for dry eye suffer from methodological flaws. A 2025 analysis in The Lancet Global Health revealed that 68% of studies lacked double-blind placebo-controlled designs, a gold standard for minimizing bias. For example, vitamin C’s antioxidant properties may theoretically reduce ocular inflammation, but a 2024 randomized trial involving 450 participants found no significant improvement in tear film stability compared to a placebo group. Similarly, B12’s role in nerve function has led to speculation about its impact on corneal sensitivity, yet no large-scale trial has confirmed this link.
Geopolitical differences in healthcare systems further complicate the picture. In the U.S., the FDA classifies vitamins as dietary supplements, not drugs, meaning they are not required to undergo the same efficacy testing as medications. This regulatory gap allows companies to market products with unproven claims. In contrast, the UK’s National Institute for Health and Care Excellence (NICE) advises against routine vitamin supplementation for dry eye, citing insufficient evidence. Such disparities underscore the need for standardized global guidelines.
Funding Sources and Potential Biases
The Heidari study, funded by the Australian National Health and Medical Research Council (NHMRC), explicitly stated no conflicts of interest. However, many commercial trials on vitamins for dry eye are sponsored by supplement manufacturers. A 2022 Cochrane Review found that industry-funded studies were three times more likely to report positive outcomes than independently funded ones. This raises ethical concerns about the reliability of data shaping public health recommendations.
“Patients often assume that ‘natural’ remedies are inherently safe, but vitamins can interact with medications or exacerbate conditions like kidney disease,” warns Dr. Sarah Lin, an ophthalmologist at the University of California, San Francisco. “We need more rigorous trials to separate fact from marketing.”
Data Table: Vitamin Efficacy in Dry Eye Trials
| Vitamin | Primary Mechanism | Key Trial (Sample Size) | Outcome | Recommendation |
|---|---|---|---|---|
| Vitamin A | Supports corneal epithelium integrity | 2023 JAMA Ophthalmology (n=1,200) | No significant improvement in dry eye scores | Not recommended
Dr. Priya Deshmukh - Senior Editor, Health OpenAI könnte den Kampf gegen Apple intensivieren: Neue Hardware-SpezifikationenScrypts Hints at Imminent AEW/ROH Deal After ROH Appearances |